TWD
MPLT

True Wealth Design’s MapLight Therapeutics MPLT Stock Holding History

True Wealth Design’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$61 – 2943
2026
Q1 		$61 Buy
+3
New +$54 ﹤0.01% 2542

Other funds holding MPLT

MSWMA
Market Street Wealth Management Advisors Indianapolis, Indiana $703M AUM 16.2% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

True Wealth Design's MPLT Position: Q2 2026 in Review

True Wealth Design sold out of MapLight Therapeutics (MPLT) in Q2 2026, closing a stake of 3 shares — an estimated $61 sold.

True Wealth Design first reported a position in MPLT in Q1 2026 and held it in 1 quarter. The position peaked at $61 in Q1 2026. 4 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

  • True Wealth Design reported no remaining MapLight Therapeutics position as of Q2 2026 after selling out during the quarter.
  • True Wealth Design sold 3 MapLight Therapeutics shares in Q2 2026, an estimated $61.
  • True Wealth Design first reported a position in MapLight Therapeutics in Q1 2026 and held it in 1 quarter.
  • True Wealth Design's MapLight Therapeutics position peaked at $61 in Q1 2026.
  • 4 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.